A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2002
10/09/2002	EP1246648A2 Dendrimer-photosensitizer complexes for medical applications
10/09/2002	EP1246640A2 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
10/09/2002	EP1246626A1 Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance
10/09/2002	EP1246624A2 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans
10/09/2002	EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
10/09/2002	EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002	EP1246620A1 Substituted acylhydroxamic acids and method of reducing tnf-g(a) levels
10/09/2002	EP1246619A1 Urotensin-ii receptor antagonists
10/09/2002	EP1246617A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system
10/09/2002	EP1246615A2 Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
10/09/2002	EP1246609A2 Micronized freeze-dried particles
10/09/2002	EP1115391B1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
10/09/2002	EP1037874B1 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
10/09/2002	EP1024798B1 Neomycin/disaccharide water solution for enteroclysis in hepatic encephalopathy
10/09/2002	EP1009411A4 Method and composition for treating sleep apnea
10/09/2002	EP0996622B1 Novel spiroazabicyclic heterocyclic compounds
10/09/2002	EP0981967B1 Feed composition for broilers and method for breeding broilers
10/09/2002	EP0973550B1 Antagonistic anti-avb3 integrin antibodies
10/09/2002	EP0971714B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia
10/09/2002	EP0967986B1 USE OF HUMAN alpha 1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION
10/09/2002	EP0964856B1 Bicyclic amino acids
10/09/2002	EP0946542B1 Indane or dihydroindole derivatives
10/09/2002	EP0837686B1 Use of indigestible oligosaccharides to treat and prevent otitis media in humans
10/09/2002	EP0833620B1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
10/09/2002	EP0804562B1 Connective tissue growth factor-2
10/09/2002	EP0769025B1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown
10/09/2002	EP0754189B1 Receptor modulating agents and methods relating thereto
10/09/2002	CN1373774A Compositions isolated from skin cells and methods for their use
10/09/2002	CN1373769A Betulinic acid derivs, having antiangiogenic activity, processes for producing such derivs. and their use for treating tumor associated angiogenesis
10/09/2002	CN1373768A Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use
10/09/2002	CN1373766A Phosphonic acid derivs, having carboxypeptidase B inhibitory activity
10/09/2002	CN1373763A Pteridinones and kinase inhibitors
10/09/2002	CN1373761A Phenanthroline-7-one derivs. and their therapeutic uses
10/09/2002	CN1373760A Quinuclidine derivs. as muscarinic M3 receptors ligand and their use
10/09/2002	CN1373755A Azacycloalkanone serine protease inhibitors
10/09/2002	CN1373754A Antibacterial agents
10/09/2002	CN1373752A Prostaglandin derivs.
10/09/2002	CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002	CN1373750A 2'-substd. 1,1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
10/09/2002	CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002	CN1373660A Method for treating chronic pain using MEK inhibitors
10/09/2002	CN1373656A Dispersion formulations contg. lipase inhibitors
10/09/2002	CN1092202C Substd. aminoalkane phosphonic acids
10/09/2002	CN1092193C Prolylendopeptidase inhibitors
10/09/2002	CN1092069C Recombinant vaccine for diseases caused by encapsulated organisms
10/09/2002	CN1092064C Nutritious health-care food for treating galactostasis
10/09/2002	CN1092061C Medicinal liquor for treating proliferation of mammary gland
10/09/2002	CN1092058C Tonic wine
10/09/2002	CN1092052C Whole deer preparation
10/09/2002	CN1092049C Composition for treating late allergic reactions and inflammation diseases, and use thereof
10/08/2002	US6462090 Formulations for detecting asthma
10/08/2002	US6462084 Gamma vinyl gamma amino butyric acid; prolonged effect; irreversible enzyme inhibitor that raises endogenous levels without addiction
10/08/2002	US6462078 Antiinflammatory agents; library of plant extracts
10/08/2002	US6462074 Substituted α, β-anellated butyrolactones
10/08/2002	US6462072 Such as 4,4-diphenylcyclohexl-1-(3,3-dimethyl-2-oxopentan-oyl)-pyrrolidine-2 -carboxylate; rotamase inhibitors; neuronal repair and regrowth; parkinson's disease, alzheimer's disease, amyotrophic lateral sclerosis
10/08/2002	US6462069 Kinase inhibitors; anticancer agents
10/08/2002	US6462064 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
10/08/2002	US6462060 Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/08/2002	US6462057 Compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
10/08/2002	US6462056 Oxazolidines as 5-HT2A-antagonists
10/08/2002	US6462048 3-(2-(4-methylpiperazin-1-yl)-benzylidene)-1,3-dihydro-indol-2-one for example; useful as psychotherapeutic agents
10/08/2002	US6462047 Containing 5- or 6-membered oxygen, nitrogen and/or sulfur heteroaryl group; angina, hypertension, respiratory distress, congestive heart failure, renal failure, atherosclerosis, inflammatory diseases, strokes, bronchitis, asthma
10/08/2002	US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002	US6462035 Binding to neuronal nicotinic acetylcholine specific receptor; modulating cholinergic function; reducing nicotine addiction; inflammatory and irritable bowel syndrome, spastic dystonia, chronic and acute pain, eating disorders
10/08/2002	US6462022 Lisinopril compositions having large-particle DCPD
10/08/2002	US6462021 Melagatran or derivative; nonvalvular atrial fibrillation; thrombotic or ischemic stroke, transient ischemic attack or systemic embolism
10/08/2002	US6462020 N-formyl-met-leu-leu-phe-phe; inhibiting release of cytokines, histamines and leukotrienes; reducing adhesion, migration and aggregation of lymphocytes, eosinophils and neutrophils; rheumatoid arthritis
10/08/2002	US6461855 Microtubule stimulated atpase activity; cancer and nervous system disorder diagnosis
10/08/2002	US6461822 Therapeutic targets for agents that suppress the release of inflammatory mediators such as interleukin il-1 and il-1 beta
10/08/2002	US6461602 Water-soluble, nontoxic prodrugs having a hydrolyzable carbamate group coupling the drug or active ingredient to a modified polymer; insoluble drug released in vivo; drug delivery
10/08/2002	US6461590 Stabilized gas-supersaturated suspensions and methods for their delivery
10/08/2002	CA2254145C Improved process to stabilize proteins
10/08/2002	CA2252982C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
10/08/2002	CA2250243C Thiazoline acid derivatives
10/08/2002	CA2196769C Benzimidazole derivatives having dopaminergic activity
10/08/2002	CA2182486C Cyclic neurokinin a antagonists
10/08/2002	CA2172354C Benzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing them
10/08/2002	CA2081766C Leukotriene b4 antagonists
10/06/2002	WO2003088897A2 Fab i inhibitors
10/06/2002	CA2444597A1 Fab i inhibitors
10/06/2002	CA2378565A1 Crystal structure
10/05/2002	CA2380381A1 Combination treatment of multiple sclerosis (ms) other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy
10/04/2002	CA2342708A1 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
10/03/2002	WO2002077267A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002	WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same
10/03/2002	WO2002077263A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002	WO2002077255A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
10/03/2002	WO2002077237A2 Transporters and ion channels
10/03/2002	WO2002077226A1 Prostaglandin ep1 receptor
10/03/2002	WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002	WO2002077199A2 Methods and products related to fgf dimerization
10/03/2002	WO2002077184A2 Oligonucleotide conjugates
10/03/2002	WO2002077074A1 Compounds for a controlled release of active compounds
10/03/2002	WO2002077031A1 Thrombin derivatives and process for producing the same, anhydrothrombin derivatives and process for producing the same, platelet agglutination-inducing compositions, method of inducing platelet agglutination, clinical test reagents, clinical test method, thrombosis inhibitors, adsorbent and process for producing the same,
10/03/2002	WO2002077027A1 Human stra6-like protein and nucleic acids encoding the same
10/03/2002	WO2002077023A2 A new essential downstream component of the wingless signalling pathway
10/03/2002	WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002	WO2002076990A1 Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
10/03/2002	WO2002076989A1 Protein phosphate inhibitors
10/03/2002	WO2002076987A1 (oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamides

1 ... 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 ... 1564